drugset / Trial / NCT03078530
Probiotic (Visbiome) for Gulf War Illness
RandomizedParallel-groupTriple-blindTreatment
Summary
The overall objective is to determine whether Visbiome will improve 1. intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2. non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.
Timeline
- Start
- 2013-09-13
- Primary completion
- 2018-05-31
- Completion
- 2018-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VSL#3 | Other / unclassified | — | — |
| Subject | Visbiome | Other / unclassified | — | — |